文献速递瓣膜外科

生物瓣与机械瓣三尖瓣置换术的早期与长期结局:一项全国性人群研究

Early and long-term outcomes of bioprosthetic versus mechanical tricuspid valve replacement: A nationwide population-based study.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-02-04

基于韩国国民健康保险服务数据库的全国性研究,纳入1241例三尖瓣置换患者,比较生物瓣(562例)与机械瓣(679例)的结局。中位随访5.6年,倾向评分匹配后显示生物瓣组全因死亡率更高(7.8 vs 4.6/100患者年,HR 1.75,95%CI 1.33-2.30,P<.001),机械瓣组卒中累积发生率更高(HR 0.65,95%CI 0.43-0.99,P=.043),生物瓣组再手术累积发生率更高(HR 4.20,95%CI 1.53-11.54,P=.005)。

要点

  • 生物瓣组全因死亡率高于机械瓣组(7.8 vs 4.6/100患者年,HR 1.75,P<.001)。
  • 机械瓣组卒中累积发生率更高(HR 0.65,95%CI 0.43-0.99,P=.043)。
  • 生物瓣组再手术累积发生率更高(HR 4.20,95%CI 1.53-11.54,P=.005)。

核心结论

  • 机械瓣三尖瓣置换术的长期生存优于生物瓣三尖瓣置换术,尤其在54至65岁年龄组机械瓣组总生存率显著更高。

研究设计与样本

  • 基于国民健康保险服务数据库的全国性研究,2003年至2018年共1425例三尖瓣置换患者,排除再次三尖瓣置换、复杂先天性心脏病、Ebstein畸形及手术时年龄小于18岁后纳入1241例。
  • 生物瓣组(B组)562例(45.3%),机械瓣组(M组)679例(54.7%),中位随访5.6年,采用倾向评分匹配,并对50至65岁患者进行亚组分析。

主要发现

  • 两组手术死亡率和术后并发症无差异。
  • 全因死亡率生物瓣组高于机械瓣组(7.8 vs 4.6/100患者年,HR 1.75,95%CI 1.33-2.30,P<.001)。
  • 卒中累积发生率机械瓣组更高(HR 0.65,95%CI 0.43-0.99,P=.043)。
  • 再手术累积发生率生物瓣组更高(HR 4.20,95%CI 1.53-11.54,P=.005)。
  • 年龄依赖的全因死亡风险分析显示,75岁以下生物瓣组风险高于机械瓣组,54至65岁间差异有统计学意义;亚组分析中生物瓣组全因死亡率亦更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared early and long-term clinical outcomes of bioprosthetic versus mechanical tricuspid valve replacement in a nationwide study based on the database from the National Health Insurance Service. METHODS: Of 1425 patients who underwent tricuspid valve replacement from 2003 to 2018, 1241 patients were enrolled after excluding retricuspid valve replacement, complex congenital heart disease, Ebstein anomaly, and age less than 18 years at operation. Bioprostheses (group B) and mechanical prostheses (group M) were used in 562 patients (45.3%) and 679 patients (54.7%), respectively. The median follow-up duration was 5.6 years. Propensity score matching was performed. Subgroup analysis was performed in patients aged 50 to 65 years. RESULTS: There was no difference in operative mortality or postoperative complications between the groups. All-cause mortality was higher in group B (7.8 vs 4.6 per 100 patient-years, hazard ratio, 1.75, 95% confidence interval, 1.33-2.30, P < .001). The cumulative incidence of stroke was higher in group M (hazard ratio, 0.65, 95% confidence interval, 0.43-0.99, P = .043), whereas the cumulative incidence of reoperation was higher in group B (hazard ratio, 4.20, 95% confidence interval, 1.53-11.54, P = .005). In terms of the age-dependent hazard of all-cause mortality, group B demonstrated a higher hazard than group M below the age of 75 years, and it was statistically significant between 54 and 65 years of age. In the subgroup analysis, all-cause mortality was also higher in group B. CONCLUSIONS: Mechanical tricuspid valve replacement demonstrated higher long-term survival than bioprosthetic tricuspid valve replacement. In particular, mechanical tricuspid valve replacement showed significantly higher overall survival between 54 and 65 years of age.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sohn SH, Kang Y, Kim JS, et al. Early and long-term outcomes of bioprosthetic versus mechanical tricuspid valve replacement: A nationwide population-based study. J Thorac Cardiovasc Surg. 2023. PMID: 36894350. doi:10.1016/j.jtcvs.2023.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。